Inspire Medical Systems, Inc. to Report Third Quarter 2025 Financial Results on November 3, 2025
Inspire Medical Systems (NYSE: INSP) will report third quarter 2025 financial results after the close of trading on Monday, November 3, 2025. Management will host a conference call at 5:00 p.m. Eastern Time to discuss results and recent business developments.
A live webcast will be available on the company’s Investor Relations page and registrants who intend to ask questions must register to receive dial‑in details and a unique access code. The company recommends registering at least 10 minutes before the call. A replay will be posted on the Investor Relations site about two hours after the call and will be archived for two weeks.
Inspire Medical Systems (NYSE: INSP) riferirà i risultati finanziari del terzo trimestre 2025 dopo la chiusura del mercato di lunedì 3 novembre 2025. Il management terrà una conference call alle 17:00 ora orientale per discutere i risultati e gli sviluppi aziendali recenti.
Una webcast dal vivo sarà disponibile sulla pagina delle Relazioni con gli Investitori dell’azienda e i Registranti che intendono porre domande devono registrarsi per ricevere i dettagli per la dial‑in e un codice di accesso unico. L’azienda consiglia di registrarsi almeno 10 minuti prima della chiamata. Una replica sarà pubblicata sul sito delle Relazioni con gli Investitori circa due ore dopo la chiamata e rimarrà archiviata per due settimane.
Inspire Medical Systems (NYSE: INSP) reportará los resultados financieros del tercer trimestre de 2025 después del cierre del mercado el lunes 3 de noviembre de 2025. La dirección realizará una conferencia telefónica a las 5:00 p.m., hora del Este para analizar los resultados y los desarollos comerciales recientes.
Una transmisión en vivo estará disponible en la página de Relaciones con Inversores de la empresa y los registrados que tengan intención de hacer preguntas deben registrarse para recibir los detalles de marcación y un código de acceso único. La empresa recomienda registrarse al menos 10 minutos antes de la llamada. Una repetición estará disponible en el sitio de Relaciones con Inversores aproximadamente dos horas después de la llamada y estará archivada por dos semanas.
Inspire Medical Systems (NYSE: INSP)는 2025년 3분기 재무 실적을 2025년 11월 3일 월요일 장 마감 후에 발표합니다. 경영진은 실적 및 최근 비즈니스 개발에 대해 논의하기 위해 북미 동부 표준시 기준 오후 5시에 컨퍼런스 콜을 주최합니다.
생방송은 회사의 투자자 관계 페이지에서 이용 가능하며, 질문을 하려는 등록자는 전화 접속 정보와 고유 액세스 코드를 받기 위해 등록해야 합니다. 회사는 콜 시작 10분 전까지 등록할 것을 권장합니다. 콜 이후 약 두 시간 뒤에 투자자 관계 사이트에 재방송이 게시되며 두 주간 보관됩니다.
Inspire Medical Systems (NYSE: INSP) publiera les résultats financiers du troisième trimestre 2025 après la clôture des marchés le lundi 3 novembre 2025. La direction animera une conférence téléphonique à 17h00, heure de l’Est pour discuter des résultats et des développements commerciaux récents.
Une webdiffusion en direct sera disponible sur la page Relations avec les investisseurs de l’entreprise et les personnes enregistrées souhaitant poser des questions doivent s’inscrire pour recevoir les détails de dial‑in et un code d’accès unique. L’entreprise recommande de s’inscrire au moins 10 minutes avant l’appel. Une rediffusion sera publiée sur le site des Relations avec les investisseurs environ deux heures après l’appel et sera archivée pendant deux semaines.
Inspire Medical Systems (NYSE: INSP) wird die Finanzergebnisse für das Dritte Quartal 2025 nach Börsenschluss am Montag, dem 3. November 2025 melden. Das Management wird eine Telefonkonferenz um 17:00 Uhr Eastern Time abhalten, um Ergebnisse und jüngste Geschäftsentwicklungen zu besprechen.
Ein Live-Webcast wird auf der Investor-Relations-Seite des Unternehmens verfügbar sein und Registranten, die Fragen stellen möchten, müssen sich registrieren, um Dial-in-Details und einen eindeutigen Zugangscode zu erhalten. Das Unternehmen empfiehlt, sich mindestens 10 Minuten vor dem Anruf zu registrieren. Eine Wiedergabe wird etwa zwei Stunden nach dem Anruf auf der Investor-Relations-Seite veröffentlicht und für zwei Wochen archiviert.
Inspire Medical Systems (NYSE: INSP) ستعلن عن نتائجها المالية للربع الثالث من عام 2025 بعد إغلاق التداول في يوم الإثنين 3 نوفمبر 2025. ستستضيف الإدارة مكالمة مؤتمر عند الساعة 5:00 مساءً بتوقيت شرق الولايات المتحدة لمناقشة النتائج والتطورات التجارية الحديثة.
سيكون هناك بث مباشر متاح على صفحة العلاقات مع المستثمرين بالشركة، ويجب على المسجلين الذين ينوون طرح أسئلة التسجيل لاستلام تفاصيل الانضمام إلى المكالمة وكود وصول فريد. توصي الشركة بالتسجيل قبل عشر دقائق على الأقل من بدء المكالمة. سيتم وضع إعادة للبث على موقع العلاقات مع المستثمرين حوالي ساعتين بعد المكالمة وسيتم أرشفته لمدة أسبوعين.
Inspire Medical Systems (NYSE: INSP) 将在 2025 年第三季度 财务业绩在 2025 年 11 月 3 日（星期一）收盘后公布。管理层将于 美东时间晚上 5:00 举行电话会议，讨论业绩及近期业务发展情况。
现场网络直播将可在公司投资者关系页面获取，计划提问的注册人须注册以接收 Dial-in 详情及唯一访问码。公司建议在通话开始前至少注册 10 分钟。通话结束约 两小时 后，投资者关系网站将发布回放，并将 保存两周。
- None.
- None.
MINNEAPOLIS, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2025 after the close of trading on Monday, November 3. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.
A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q3 2025 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.
If you plan to ask a question, please use the following link: Inspire's Q3 2025 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call.
Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
FAQ
When will Inspire Medical Systems (INSP) report Q3 2025 results?
What time is the INSP Q3 2025 earnings call and how can I join?
How do I register to ask a question on the INSP Q3 2025 call?
When will the Q3 2025 earnings replay for INSP be available?
Where can investors find the INSP Q3 2025 webcast link?
Any registration tips for the INSP November 3, 2025 earnings call?
